MTOR and breast cancer: Based on several studies, it is thought that UCA1 either manipulates the mTOR signaling pathway and/or exploits an miR-18a-HIF1α feedback loop as well as the Wnt/β-catenin signaling pathway to confer tamoxifen resistance in breast cancer [19, 79].